+181.2%
MRNA vs FN
+83.1%
+98.1%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | FN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.6% | -5.2% | +1.5% | -3.0% |
| 7D | -20.0% | -15.0% | -5.0% | -18.3% |
| 30D | -1.3% | -14.4% | +13.2% | +0.3% |
| 3M | +240.0% | -45.5% | +285.4% | +262.6% |
| 6M | +339.0% | -56.9% | +395.9% | +384.0% |
| YTD | +630.0% | -31.7% | +661.7% | +604.7% |
| 1Y | +769.1% | -24.8% | +793.8% | +719.0% |
| 3Y | +181.2% | +84.8% | +96.4% | +74.2% |
| All | +181.2% | +83.1% | +98.1% | +74.2% |
Cumulative growth
Daily Returns
Daily percentage return beside FN.
Daily Out/Under-Performance
Portfolio return minus FN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded FN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling